Clearside Biomedical's Series A Round

Clearside Biomedical raised a round of funding on January 05, 2012. Investors include Hatteras Venture Partners.

Clearside Biomedical, headquartered in Alpharetta, GA, is a clinical-stage biopharmaceutical company developing innovative first-in-class drug therapies to treat blinding diseases of the eye using Cle…

Articles about Clearside Biomedical's Series A Round: